Clinical characteristics and treatment outcome of acute myeloid leukemia in elderly patients in Korea: a retrospective analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yi, Hyeon Gyu | - |
dc.contributor.author | Lee, Moon Hee | - |
dc.contributor.author | Kim, Chul Soo | - |
dc.contributor.author | Hong, Junsik | - |
dc.contributor.author | Park, Jinny | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.contributor.author | Han, Bo Ram | - |
dc.contributor.author | Kim, Ho Young | - |
dc.contributor.author | Zang, Dae Young | - |
dc.contributor.author | Kim, Se Hyung | - |
dc.contributor.author | Park, Seong Kyu | - |
dc.contributor.author | Hong, Dae Sik | - |
dc.contributor.author | Lee, Guk Jin | - |
dc.contributor.author | Jin, Jong-Youl | - |
dc.date.accessioned | 2021-08-11T22:46:07Z | - |
dc.date.available | 2021-08-11T22:46:07Z | - |
dc.date.issued | 2014-06 | - |
dc.identifier.issn | 2287-979X | - |
dc.identifier.issn | 2288-0011 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/12188 | - |
dc.description.abstract | Background The clinical characteristics of elderly patients with AML differ from those of younger patients, resulting in poorer survival and treatment outcomes. We analyzed retrospectively the clinical data of AML patients 65 years old and above to describe patients' characteristics and treatment patterns, and to define meaningful prognostic factors of survival in the Korean population. Methods Basic patients' characteristics, clinical outcomes according to treatments, and prognostic factors associated with survival and treatment intensity were examined in a total of 168 patients diagnosed in 5 institutes between 1996 and 2012 as having AML. Results Herein, 84 patients (50.0%) received high-intensity regimens (HIR), 18 (10.7%) received low-intensity regimens (LIR), and 66 (39.3%) received supportive care (SC) only. The median survival of all patients was 4.5 months; and median survival times with HIR, LIR, and SC were 6.8 months, 10.2 months, and 1.6 months, respectively. Median survival times with HIR and LIR were significantly longer than that with SC (P<0.0001 and P=0.006, respectively). Multivariate analysis identified age, Eastern Cooperative Oncology Group-performance status (ECOG-PS), hemoglobin (Hb) level, and serum creatinine (Cr) level as statistically significant prognostic factors for survival. In the HIR group, prognostic factors for survival were ECOG-PS, Hb level, and C-reactive protein level. Conclusion Even in elderly AML patients, an intensive treatment regimen could be beneficial with careful patient selection. Further prospective studies designed to identify specific prognostic factors are required to establish an optimal treatment strategy for elderly AML patients. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한혈액학회 | - |
dc.title | Clinical characteristics and treatment outcome of acute myeloid leukemia in elderly patients in Korea: a retrospective analysis | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5045/br.2014.49.2.95 | - |
dc.identifier.scopusid | 2-s2.0-84903523309 | - |
dc.identifier.wosid | 000433683900007 | - |
dc.identifier.bibliographicCitation | Blood Research, v.49, no.2, pp 95 - 99 | - |
dc.citation.title | Blood Research | - |
dc.citation.volume | 49 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 95 | - |
dc.citation.endPage | 99 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001882806 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.subject.keywordAuthor | Acute myeloid leukemia | - |
dc.subject.keywordAuthor | Survival | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Chemotherapy | - |
dc.subject.keywordAuthor | Elderly | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.